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Purpose/Objective: The atlas-based automatic segmentation can 
significantly reduce contouring time. A multi-atlas method has been 
shown to provide greater accuracy than a single best matched (SBM) 
method. In this work, we evaluated the multi-atlas based 
segmentation using majority voting approach for head and neck (H&N) 
and prostate cancer. 
Materials and Methods: 50 prostate atlases and 20 H&N atlases were 
developed and utilized for atlas-based segmentation. Prostate atlas 
contained CT images and manually defined contours of the prostate, 
seminal vesicles, rectum and bladder. H&N atlas contained CT images 
and manually defined contours of the brain stem, spinal cord, 
parotids, constrictor muscle, larynx, oral cavity and thyroid. SBM used 
one automatically selected best match atlas. Multi-atlas used multiple 
automatically selected best matches (3, 4, 5, and 10, respectively). 
And, the final segmentation fused the individual segmentations using 
majority vote rule. We performed automatic segmentation using SBM 
and multi-atlas for 10 prostate subjects and 10 H&N subjects. Average 
dice coefficients were calculated for each structure to compare 
against manually defined contours for subjects. 
Results: In prostate case, average dice coefficients of multi-atlas (3, 
4, 5, and 10) and SBM were 0.686 ± 0.192, 0.693 ± 0.192, 0.716 ± 
0.208, 0.768 ± 0.141 and 0.650 ± 0.182, respectively. There was a 
statistically significant difference between SBM and multi-atlas: 10 (P 
= 0.0014). In H&N case, average dice coefficients of multi-atlas (3, 4, 
5, and 10) and SBM were 0.709 ± 0.176, 0.737 ± 0.159, 0.740 ± 0.157, 
0.757 ± 0.132 and 0.715 ± 0.166, respectively. There was a 
statistically significant difference between SBM and multi-atlas: 10 (P 
= 0.0062). 
Conclusions: The multi-atlas based segmentation using majority 
voting was greater accuracy than SBM for H&N and prostate cancer. 
The multi-atlas based segmentation was more accurate with 
increasing the number of fused atlas. 
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Purpose/Objective: To compare the TomoTherapy® System's 
TomoDirect™ modality to the standard 3DRT technique for the 
postoperative breast radiotherapy. 
Materials and Methods: We compared the treatment plans of 30 
patients consecutively treated from February to May 2012 with the 
new TomoTherapy® System's TomoDirect™ (TD) modality for 
postoperative breast radiotherapy. The TomoDirect™ was 
implemented in our Institute from January 2012. Clinical target 
volumes (CTV) and organs at risk (OAR) were contoured for all the 
patients by the same physician to avoid interobserver variability; a 
PTV was generated by adding a 5 mm uniform margin to the CTV. 
Patients underwent the whole breast irradiation and a simultaneous 
integrated boost to the tumor bed region. The prescribed doses (at 
the 95% isodose) were 2.25-2.50 Gy/fraction up to a total dose of 45-
50 Gy (20 fractions) to the whole breast and to the postsurgical area 
respectively. Plans for TD and 3DRT were both optimized, according 
to our Intitutional protocol, in terms of dose coverage to target and 
constraints. The constraints routinely used refer to a dose of 
2Gy/fraction andare: PTV(breast), V95%≥95%, D50%£108%, 
V100%(boost dose)£30%, Dmax£115%; PTV(boost), V95%≥95%, 
Dmax<115%; Heart (right breast),Dmax<16-20Gy,V8Gy<10-15%; Heart 
(left breast), D5%<16-20Gy,V8Gy<30-35%;Heart (right/left breast) 
Dmean<3.2-4Gy; Ipsilateral lung V16Gy<15-20%,V8Gy<35-40%, 
V4Gy<50%, Controlateral lung V4Gy<10-15%;Controlateral breast 
Dmax<2.4-2.6Gy. 
Results: The dosimetric comparison related to the PTVs and to the 
OARs DVHs are reported in the Table as mean values (%) plus/minus 
the standard deviation (%). Controlateral breast maximum dose 
resulted: 2.9±2.6Gy, 2.5±2.2Gy for 3DCRT andTD respectively, while 
Controlateral lung maximum dose is about 0 Gy in both cases. 
Concerning the treatment time and the planned monitor units, the 
firsts where378±55s and 95±15s while the monitor units were 




Conclusions: TD was investigated as an alternative technique to the 
3D conformal one for the postoperative breast radiotherapy. DVHs 
show an improvements in PTV coverage and Heart sparing. On the 
contrary, the treatment time and the monitor units of the TD 
technique are about 4 and 18 times those of the 3DRT. The real 
advantage of the TomoDirect™ is the possibility of performing the 
image guided radiotherapy and in this case results suggest that the 
use of the TD technique is definitely favourable. 
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Purpose/Objective: To investigate the advanced radiotherapy 
treatments of cutaneous Kaposi’s sarcoma of lower extremities with 
adequate target coverage and bone high sparing with volumetric 
modulated arc therapy (VMAT, RapidArc (RA)) in comparison to 
electron beams. 
Materials and Methods: Ten patients were planned with RA and, 
alternatively, with electron beams. Patients presented superficial 
target volumes adjacent to the leg’s bones and extending from the 
knees to the base of the foot in 7out of 10. Target volume longitudinal 
length was in average 45±12cm (range 29-66 cm). Dose was prescribed 
to 30Gy in 10 fractions to mean planning target volume (PTV), and 
significant maximum dose to the bone was limited to 30Gy. Plans 
were designed for 6MV photon beams for RA and 6MeV for electrons. 
For RA two groups of plans were generated: the first, RA_1, with the 
aim of respecting planning objectives for target coverage, 
homogeneity and maximum dose to the bones, the second group, 
RA_2,was generated adding the request to maximise bone sparing 
without significant compromises to target objectives. Dose 
distributions were computed with AcurosXB for photons and with 
Monte Carlo for the electrons. 
Results: Given the specificity of the target, PTV coverage was 
acceptably for both RA_1 (V95%>95%,V107%<0.5%) and RA_2 plans 
(V90%>95% V107%<5.0%) respecting the objective of a bone sparing with 
D2%<30Gy, while, although acceptable for bone involvement, 
pronounced target coverage violations were obtained for electron 
plans. MU resulted comparable for electrons and RA although the 
latter increased when a superior bone sparing was imposed, reaching, 
however, a significant improvement also respect electrons plans on all 
the analyzed parameters for bone DVHs (D2%, D10cm3 and D20cm3, and Vx 
with x=10, 20, 30Gy, mean dose). Delivery time were 12.1±4.0 
minutes for electrons and 4.8±1.3 minutes for the most modulated RA 
plans (RA_2). 
Conclusions: High plan quality was shown for Kaposi sarcoma in the 
lower extremities using VMAT and this might simplify the management 
of these treatments in comparison to more conventional usage of 
electrons, particularly in institutes with limited staff resources and 
heavy workloads. In addition, VMAT demonstrated dosimetrically 
extremely advantageous and a flexible approach also in a typology of 
treatments where electron beam therapy is mainly considered to be 
effective due to the limited penetration of the beams.  
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